The global pharmacy benefit management market is expected to exhibit a growth rate (CAGR) of 5.65% during 2023-2028. The rising need for cost management of prescription drugs, the integration of machine learning (ML) and artificial intelligence (AI) technologies and shifting preference towards PBM systems are some of the major factors propelling the market.
Pharmacy benefit management (PBM) refers to the third-party entities that administer prescription drug programs on behalf of health insurance plans, employers, and other organizations. PBMs play a crucial role in managing and optimizing the pharmaceutical benefits provided to plan members or employees. They act as intermediaries between pharmacies, drug manufacturers, and healthcare payers, facilitating the effective and efficient delivery of prescription medications. PBMs perform various functions, including negotiating drug prices with pharmaceutical companies, developing, and maintaining formularies, processing prescription claims, and managing pharmacy networks. PBMs aim to control prescription drug costs, promote generic drug utilization, ensure medication safety, and improve overall health outcomes.
The market growth is primarily driven by the need for cost management of prescription drugs. Furthermore, rising drug prices have further boosted the demand for pharmacy benefit management (PBM) among health insurance providers, creating lucrative opportunities for market growth. Moreover, the availability of similar drugs in the market with minor differences in their active pharmaceutical ingredient (API) has increased price sensitivity among consumers, leading to an increased demand for PBM services. Additionally, the integration of machine learning (ML) and artificial intelligence (AI) technologies has played a vital role in improving workflow efficiency. These technologies streamline the supply chain, facilitate faster order delivery, and cater to multiple insurance and retail pharmacy chains within a limited timeframe. Moreover, there is a shifting preference towards PBM systems due to their ability to provide better expertise and connections with pharmaceutical companies. PBM systems facilitate the establishment of drug contracts and enable access to medicines across various retail pharmacy networks.
Pharmacy Benefit Management Market Trends/Drivers:
The Rising Prevalence of Chronic Disorders
The widespread prevalence of chronic diseases is significantly influencing the pharmacy benefit management (PBM) market. Chronic diseases, such as diabetes, cardiovascular diseases, respiratory conditions, and autoimmune disorders, have become a global health challenge. These diseases often require long-term medication management, monitoring, and specialized care. As a result, the demand for pharmacy benefits that cover the treatment of chronic diseases has grown substantially. PBMs also work closely with healthcare providers to develop formularies that include a range of effective treatment options for chronic diseases. Furthermore, PBMs implement medication therapy management programs, adherence support initiatives, and care coordination services to enhance patient outcomes and reduce healthcare costs associated with chronic diseases. Additionally, PBMs contribute to improved disease management, better patient adherence, and overall health outcomes in the face of the growing burden of chronic diseases worldwide.
Enhanced Patient Care and Health Outcomes
Improving patient care and health outcomes is a significant driver for PBM involvement. PBMs offer various clinical support services to optimize medication therapy, enhance patient safety, and improve health outcomes. These services may include medication therapy management, which involves medication reviews, adherence monitoring, and personalized interventions to address medication-related issues. By utilizing data analytics and real-time prescription monitoring, PBMs can identify potential drug interactions, therapeutic duplications, and adherence issues, enabling timely interventions and improved patient care. Moreover, through their efforts to control costs, enhance medication access, and optimize clinical outcomes, PBMs contribute to better overall health management for individuals covered under pharmacy benefit programs.
Continual Advancements in Technology and Data Analytics
Continual improvements and the increasing availability of healthcare data are driving significant changes in the PBM market. PBMs are harnessing the power of data analytics, artificial intelligence, and machine learning to improve their operations and deliver more personalized, data-driven pharmacy benefit solutions. Advanced analytics enable PBMs to identify trends, predict medication adherence patterns, and optimize formulary design. Real-time data monitoring helps prevent medication errors and improve patient safety. Additionally, technological innovations facilitate seamless integration between PBMs, pharmacies, and healthcare providers, enabling smoother claims processing, better coordination of care, and enhanced patient experiences. As technology continues to advance, PBMs that leverage these tools effectively will have a competitive edge in delivering efficient and impactful pharmacy benefit management services.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Pharmacy Benefit Management Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global pharmacy benefit management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on service, business model and end use.
Breakup by Service:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Specialty Pharmacy Services
- Drug Formulary Management
- Retail Pharmacy Services
- Benefit Plan Design and Consultation
- Disease Management Services
Specialty pharmacy services equipment dominates the market
The report has provided a detailed breakup and analysis of the market based on the service. This includes specialty pharmacy services, drug formulary management, retail pharmacy services, benefit plan design and consultation, disease management services, and others. According to the report, speciality pharmacy services represented the largest segment.
Specialty pharmacy services have emerged as the largest service segment within the pharmacy benefit management (PBM) market. Specialty pharmacy services cater to the unique needs of patients requiring complex and high-cost medications for chronic, rare, or life-threatening conditions. This service segment focuses on the management and distribution of specialty pharmaceuticals, which often require specialized handling, storage, and patient support. They provide comprehensive services that go beyond traditional pharmacy services. They offer personalized medication counseling, adherence support programs, prior authorization assistance, financial assistance coordination, and ongoing patient monitoring. These services are designed to optimize therapy outcomes, enhance patient adherence, and improve overall treatment effectiveness. There has been a significant increase in the utilization of specialty medications due to advancements in medical technology and the introduction of innovative therapies. These medications often require complex administration, close monitoring, and patient education, which specialty pharmacies are well-equipped to provide.
Breakup by Business Model:
- Health Insurance Management
- Standalone PBMs
- Retail Pharmacy
Health insurance management hold the largest share in the market
A detailed breakup and analysis of the market based on the business model has also been provided in the report. This includes health insurance management, standalone PBMs, and retail pharmacy. According to the report, health insurance management accounted for the largest market share.
In the pharmacy benefit management (PBM) market, the largest business model segment is health insurance management. This segment involves PBMs working directly with health insurance companies to administer and manage prescription drug benefits for their members. PBMs serve as strategic partners to health insurance providers, offering a range of services to optimize the pharmacy benefits offered to their members. These services include formulary development, drug pricing negotiations, claims processing, pharmacy network management, and utilization management. PBMs leverage their purchasing power and negotiation expertise to secure favorable pricing agreements with pharmaceutical manufacturers, ensuring cost-effective drug coverage for insurance plans. PBMs help health insurance companies streamline their pharmacy benefit operations, allowing insurers to focus on their core competencies in healthcare coverage. PBMs handle various administrative tasks related to prescription drugs, such as claims processing, prior authorization, and pharmacy network management.
Breakup by End Use:
Commercial dominates the market
The report has provided a detailed breakup and analysis of the market based on the end use. This includes federal and commercial. According to the report, commercial represented the largest segment.
The dominance of the commercial end-use segment can be attributed to several factors, such as several businesses and employers offer health insurance benefits to attract and retain employees. As a result, there is a significant demand for PBMs to manage the pharmacy benefits associated with these commercial health insurance plans. PBMs work closely with employers and insurance providers to design and administer comprehensive pharmacy benefit programs that meet the unique needs of the covered population. Moreover, the commercial segment benefits from the size and scale of employee health insurance plans. PBMs leverage their negotiating power to secure competitive drug pricing agreements with pharmaceutical manufacturers, ensuring cost-effective pharmacy benefits for employees and employers alike. Additionally, the commercial end-use segment encompasses a wide range of industries and businesses, including small, medium, and large enterprises across various sectors.
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- United Kingdom
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, and others), Asia-Pacific (China, Japan, India, Australia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa (Saudi Arabia, South Africa, United Arab Emirates, and Others). According to the report, North America accounted for the largest market share.
North America exhibits a clear dominance in terms of regional market share. The United States has a complex healthcare landscape with a large population and a significant focus on pharmaceuticals. The country has a well-developed private health insurance sector and a high prevalence of employer-sponsored health plans, driving the demand for PBM services. PBMs in North America play a pivotal role in negotiating drug prices, managing formularies, and controlling prescription drug costs, which is crucial in a healthcare system with high drug prices. The country also has a complex healthcare landscape with a large population and a significant focus on pharmaceuticals. Moreover, the country has a well-developed private health insurance sector and a high prevalence of employer-sponsored health plans, augmenting the demand for PBM services. Also, the strong regulatory framework and well-defined reimbursement policies in North America provide a favorable environment for PBMs to operate.
Companies in the pharmacy benefit management (PBM) market are engaged in various activities and services to effectively manage prescription drug benefits for their clients. Several leading players are developing and managing formularies, which are lists of covered medications for specific health insurance plans or employer groups. They assess the clinical effectiveness, safety, and cost-effectiveness of drugs to determine their inclusion in the formulary. PBMs negotiate with pharmaceutical manufacturers to secure favorable pricing for formulary drugs, ensuring access to affordable and appropriate medications. Additionally, PBMs offer various patient support services to enhance medication adherence and patient engagement. These services may include 24/7 pharmacist helplines, medication refill reminders, educational materials, and personalized patient counseling to address concerns or questions related to medications. Moreover, PBMs leverage data analytics to gather insights, identify trends, and make data-driven decisions.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Aetna, Inc.
- Centene Corporation
- Cigna Corporation
- CVS Health Corporation
- Express Scripts Holding Company
- Magellan Health, Inc.
- Medimpact Healthcare Systems, Inc.
- Optumrx, Inc.
- Prime Therapeutics LLC
- ProCare Rx
- SS&c Technologies, Inc.
- In May 2022, CVS Health Corporation launch new virtual primary care solution on a single digital platform. This offers access to primary care, on-demand care, chronic condition management, and mental health services virtually, with the option of being seen in-person when needed at an in-network provider. It can also help members identify appropriate in-network specialists and other in-network health service providers, if necessary.
- In May 2022, ProCare Rx announced that it will now be the primary Pharmacy Benefits Management (PBM) organization within the ProCare family of businesses. This collaboration will assist in providing the most focused, high-quality services to the client partners.
- In March 2021, Medimpact Healthcare Systems, Inc launches artificial intelligence FWA Solution. The solution, powered by machine learning and artificial intelligence (AI), promotes payment integrity, compliance, and member safety.
Pharmacy Benefit Management Market Report Scope:
|Base Year of the Analysis
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Business Model
- End Use
||Specialty Pharmacy Services, Drug Formulary Management, Retail Pharmacy Services, Benefit Plan Design and Consultation, Disease Management Services, Others
|Business Models Covered
||Health Insurance Management, Standalone PBMS, Retail Pharmacy
|End Uses Covered
||North America, Europe, Asia Pacific, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, United Arab Emirates
||Aetna, Inc., Centene Corporation, Cigna Corporation, CVS Health Corporation, Express Scripts Holding Company, Magellan Health, Inc., Medimpact Healthcare Systems, Inc., Optumrx, Inc., Prime Therapeutics LLC, ProCare Rx, SS&c Technologies, Inc. etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the pharmacy benefit management market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global pharmacy benefit management market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the pharmacy benefit management industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.